{
    "title": "Teva sees return to growth after opioid settlement, shares jump",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11054339/Teva-Pharm-sees-return-growth-post-opioid-settlement.html",
    "date": "2022-07-27",
    "keywords": [
        "settlement",
        "york",
        "teva",
        "growth",
        "schultz",
        "revenue",
        "debt",
        "crisis",
        "market",
        "drug",
        "copaxone",
        "agreement",
        "company",
        "state",
        "ajovy",
        "austedo",
        "year",
        "reporting",
        "scheer",
        "jerusalem",
        "july",
        "forecast",
        "midsingle",
        "overhang",
        "role",
        "drugmaker",
        "competition",
        "blockbuster",
        "sclerosis",
        "tuesday",
        "cash",
        "executive",
        "kare",
        "figure",
        "principle",
        "host",
        "effect",
        "wednesday",
        "relief",
        "judgment",
        "jury",
        "december",
        "value",
        "government",
        "deal",
        "beginning",
        "conference",
        "call",
        "foundation",
        "treatment",
        "europe",
        "lymphoma",
        "share",
        "patent",
        "decade",
        "pipeline",
        "addition",
        "income",
        "margin",
        "level",
        "position",
        "product",
        "portfolio",
        "time",
        "manufacturing",
        "world",
        "leader",
        "knauth",
        "editing",
        "jan",
        "harvey",
        "angus",
        "macswan",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}